NCT01825850

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

A Randomized, Open Label Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Irbesartan in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: LG Life Sciences · Industry
• Sex: Male
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The objective of the study is to investigate the drug interaction between Gemigliptin and Irbesartan by comparing pharmacokinetics of Gemigliptin and Irbesartan administered concomitantly and each alone in healthy male subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Gemigliptin
DRUG	Irbesartan

Timeline

• Start date: 2013-06-01
• Primary completion: 2013-09-01
• Completion: 2014-03-01
• First posted: 2013-04-08
• Last updated: 2014-12-30

Locations

1 site across 1 country: South Korea